Functional interaction of HTLV-1 Tax protein with the POZ domain of the transcriptional repressor BCL6

Oncogene

Volumn 28, Issue 42, 2009, Pages 3723-3734

  Dean, J ^a   Hashimoto, K ^a,b   Tsuji, T ^a,c   Gautier, V ^a   Hall, W W ^a   Sheehy, N ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Department of Neurology   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

BCL6; HTLV 1; Tax 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; PROTEIN BCL 6; TAX PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE SILENCING; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; KIDNEY CELL; LONG TERMINAL REPEAT; OSTEOSARCOMA CELL; POXVIRUS; POZ DOMAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; T LYMPHOCYTE; VIRUS GENE; ZINC FINGER MOTIF;

APOPTOSIS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAX; GENE SILENCING; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NF-KAPPA B; POXVIRIDAE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TERMINAL REPEAT SEQUENCES; TWO-HYBRID SYSTEM TECHNIQUES; ZINC FINGERS;

HUMAN T-LYMPHOTROPIC VIRUS 1; POXVIRIDAE;

EID: 70350575148     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.230     Document Type: Article

References (64)

1. Albagli O, Dhordain P, Bernardin F, Quief S, Kerkaert JP, Leprince D. (1996). Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression. Biochem Biophys Res Commun 220: 911-915.
2. Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP et al. (1999). Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci. Oncogene 18: 5063-5075.
3. Albagli O, Lindon C, Lantoine D, Quief S, Puvion E, Pinset C et al. (2000). DNA replication progresses on the periphery of nuclear aggregates formed by the BCL6 transcription factor. Mol Cell Biol 20: 8560-8570.
4. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.
5. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC et al. (2002). The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci USA 99: 2860-2865.
6. Baron BW, Nucifora G, McCabe N, Espinosa 3rd R, Le Beau MM, McKeithan TW. (1993). Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90: 5262-5266.
7. Baron BW, Zeleznik-Le N, Baron MJ, Theisler C, Huo D, Krasowski M et al. (2007). Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Natl Acad Sci USA 104: 7449-7454.
8. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B et al. (1995). BCL-6 protein is expressed in germinal-center B cells. Blood 86: 45-53.
9. Chen W, Iida S, Louie DC, Dalla-Favera R, Chaganti RS. (1998). Heterologous promoters fused to BCL6 by chromosomal transloca-tions affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood 91: 603-607.
10. Chang CC, Ye BH, Chaganti RS, Dalla-Favera R. (1996). BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA 93: 6947-6952.
11. Cheng J, Kydd AR, Nakase K, Noonan KM, Murakami A, Tao H et al. (2007). Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein. Blood 110: 2110-2120.
12. Delebecque F, Pramberger K, Prevost MC, Brahic M, Tangy F. (2002). A chimeric human T-cell lymphotropicvirus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells. J Virol 76: 7883-7889.
13. Dhordain P, Albagli O, Ansieau S, Koken MH, Deweindt C, Quief S et al. (1995). The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. Oncogene 11: 2689-2697.
14. Dhordain P, Albagli O, Honore N, Guidez F, Lantoine D, Schmid M et al. (2000). Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Oncogene 19: 6240-6250.
15. Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, Leutz A et al. (1997). Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci USA 94: 10762-10767.
16. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM et al. (1998). The LAZ3(BCL-6) oncoprotein recruits a SMRT/ mSIN3A/histone deacetylase containing complex to mediate tran-scriptional repression. Nucleic Acids Res 26: 4645-4651.
17. Gabet AS, Mortreux F, Charneau P, Riou P, Duc-Dodon M, Wu Y et al. (2003). Inactivation of hTERT transcription by Tax. Oncogene 22: 3734-3741.
18. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM et al. (1994). Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 84: 397-402.
19. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A et al. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410.
20. Giebler HA, Loring JE, Van Orden K, Colgin MA, Garrus JE, Escudero KE et al. (1997). Anchoring of CREB binding protein to the human T-cell leukemia virus type-1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol 17: 5156-5164.
21. Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG et al. (1992). Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol 66: 4570-4575.
22. Grassmann R, Dengler C, Muller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar MC et al. (1989). Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci USA 86: 3351-3355.
23. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y et al. (2006). Thymus-derived leukemia-lymphoma in mice trans-genic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12: 466-472.
24. Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N, Yamaoka S. (2004). Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia 6: 266-278.
25. Huynh KD, Bardwell VJ. (1998). The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17: 2473-2484.
26. Huynh KD, Fischle W, Verdin E, Bardwell VJ. (2000). BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14: 1810-1823.
27. Hyjek E, Chadburn A, Liu YF, Cesarman E, Knowles DM. (2001). BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood 97: 270-276.
28. Ichii H, Sakamoto A, Arima M, Hatano M, Kuroda Y, Tokuhisa T. (2007). Bcl6 is essential for the generation of long-term memory CD4+ T cells. Int Immunol 19: 427-433.
29. Ichii H, Sakamoto A, Hatano M, Okada S, Toyama H, Taki S et al. (2002). Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat Immunol 3: 558-563.
30. Jeang KT, Widen SG, Semmes 4th OJ, Wilson SH. (1990). HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 247: 1082-1084.
31. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, Nakatani Y et al. (2000). PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol 19: 8136-8145.
32. Kelly KF, Daniel JM. (2006). POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 16: 578-587.
33. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. (1993). LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5: 66-70.
34. Kibler KV, Jeang KT. (2001). CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein. J Virol 75: 2161-2173.
35. Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK. (2004). Transcription regulatory complexes bind the human T-cell leukemia virus 50 and 30 long terminal repeats to control gene expression. Mol Cell Biol 24: 6117-6126.
36. Lemercier C, Brocard MP, Puvion-Dutilleul F, Kao HY, Albagli O, Khochbin S. (2002). Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J Biol Chem 277: 22045-22052.
37. Li Z, Wang X, Yu RY, Ding BB, Yu JJ, Dai XM et al. (2005). BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit. J Immunol 174: 205-214.
38. Lu H, Pise-Masison CA, Linton R, Park HU, Schiltz RL, Sartorelli V et al. (2004). Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. J Virol 78: 6735-6743.
39. Matsuoka M, Jeang KT. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270-280.
40. Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, Bardwell V et al. (2002). Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol 22: 1804-1818.
41. Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW et al. (1999). Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93: 2360-2368.
42. Nakayama T, Hieshima K, Arao T, Jin Z, Nagakubo D, Shirakawa AK et al. (2008). Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia. Oncogene 27: 3221-3232.
43. Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N et al. (1995). BCL-6 gene product, a 92-to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86: 28-37.
44. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A et al. (1986). HTLV-1 associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
45. Perez-Rosado A, Artiga M, Vargiu P, Sanchez-Aguilera A, Alvarez-Barrientos A, Piris M. (2008). BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas. J Pathol 214: 498-507.
46. Phan RT, Dalla-Favera R. (2004). The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432: 635-639.
47. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. (2005). BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 6: 1054-1060.
48. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419.
49. Pozzatti R, Vogel J, Jay G. (1990). The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol 10: 413-417.
50. Ranuncolo SM, Polo JM, Dierov J, Singer M, Kuo T, Greally J et al. (2007). Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol 8: 705-714.
51. Ranuncolo SM, Wang L, Polo JM, Dell'Oso T, Dierov J, Gaymes TJ et al. (2008). BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner. J Biol Chem 283: 22565-22572.
52. Seyfert VL, Allman D, He Y, Staudt LM. (1996). Transcriptional repression by the proto-oncogene BCL-6. Oncogene 12: 2331-2342.
53. Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, Pickeral OK et al. (2001). Signatures of the immune response. Immunity 15: 375-385.
54. Sheehy N, Lillis L, Watters K, Lewis M, Gautier V, Hall W. (2006). Functional analysis of human T lymphotropic virus type 2 Tax proteins. Retrovirology 3: 20.
55. Stogios PJ, Downs GS, Jauhal JJ, Nandra SK, Prive GG. (2005). Sequence and structural analysis of BTB domain proteins. Genome Biol 6: R82.
56. Sun SC, Yamaoka S. (2005). Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 24: 5952-5964.
57. Suzuki T, Fujisawa JI, Toita M, Yoshida M. (1993). The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA 90: 610-614.
58. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. (1990). Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87: 1071-1075.
59. Tsuji T, Sheehy N, Gautier VW, Hayakawa H, Sawa H, Hall WW. (2007). The nuclear import of the human T lymphotropic virus type I (HTLV-1) tax protein is carrier-and energy-independent. J Biol Chem 282: 13875-13883.
60. Yamochi T, Kaneita Y, Akiyama T, Mori S, Moriyama M. (1999). Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L). Oncogene 18: 487-494.
61. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS et al. (1993). Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262: 747-750.
62. Yoshida M, Miyoshi I, Hinuma Y. (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031-2035.
63. Zhang H, Okada S, Hatano M, Okabe S, Tokuhisa T. (2001). A new functional domain of Bcl6 family that recruits histone deacetylases. Biochim Biophys Acta 1540: 188-200.
64. Zhao LJ, Giam CZ. (1991). Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc Natl Acad Sci USA 88: 11445-11449.